Two cancer drugs prevent, reverse type 1 diabetes, study shows

Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco. The drugs - imatinib (marketed as Gleevec) and sunitinib (marketed as Sutent) - were found to put type 1 diabetes into remission in 80 percent of the test mice and work permanently in 80 percent of those that go into remission.

Read the whole article on Physorg

More from Physorg